Utilized to manage type 2 diabetes by addressing insulin secretion to support glucose stabilization and alleviate long-term risks of nerve and kidney damage.
Mechanism of Action
Glimepiride triggers the pancreas to release more insulin. Insulin is the hormone that helps move sugar from the blood into the cells. By increasing insulin levels, the drug effectively lowers high blood glucose.
Route of Administration
Oral
Onset Time
2–3 hours
Duration
24 hours
Contraindications
Type 1 diabetes, Diabetic ketoacidosis, Hypersensitivity to sulfonylureas, Severe liver or kidney disease
Severe Adverse Events
Severe low blood sugar, Liver toxicity, Severe skin reactions, Low platelet count, Anaphylaxis, Hemolytic anemia
Information for Glimepiride is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
